Page last updated: 2024-10-21

1,2-dimethylhydrazine and Lymphoma, Non-Hodgkin

1,2-dimethylhydrazine has been researched along with Lymphoma, Non-Hodgkin in 1 studies

1,2-Dimethylhydrazine: A DNA alkylating agent that has been shown to be a potent carcinogen and is widely used to induce colon tumors in experimental animals.
1,2-dimethylhydrazine : A member of the class of hydrazines that is hydrazine in which one of the hydrogens attached to each nitrogen is replaced by a methyl group. A powerful DNA alkylating agent and carcinogen, it is used to induce colon cancer in laboratory rats and mice.

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colussi, C1
Fiumicino, S1
Giuliani, A1
Rosini, S1
Musiani, P1
Macrí, C1
Potten, CS1
Crescenzi, M1
Bignami, M1

Other Studies

1 other study available for 1,2-dimethylhydrazine and Lymphoma, Non-Hodgkin

ArticleYear
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.
    Journal of the National Cancer Institute, 2001, Oct-17, Volume: 93, Issue:20

    Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Alkylating Agents; Animals; Apoptosis; Base Pair Mismatch; Ca

2001